And that Rossi70 is the concern that will prevent it from being considered as an accelerated option because it is so novel and alters cell state. Engineering cells isn't something that people are lining up for on buses and for good reason.
The road ahead may be successful but is certainly long and decades away.
- Forums
- ASX - By Stock
- CYP
- Ann: Investor Presentation
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.0¢

Ann: Investor Presentation, page-564
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 16.0¢ | $1.021K | 6.379K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 77738 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 3400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 77738 | 0.160 |
4 | 148709 | 0.155 |
4 | 86673 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 3400 | 1 |
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 146968 | 5 |
0.185 | 35990 | 1 |
Last trade - 09.59am 24/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |